PS Ratio: 16.08

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 16.08 is 42% below its estimated 5-year average of 27.93, near the low end of its estimated 5-year range (4.80–256772.76).

As of 2026-10-02T19:40:13.826Z. 47.88% below its estimated 12-month average of 30.85.

BEAM PS Ratio Metrics

P/S vs. estimated history

At 16.08, P/S is below its estimated 7-year median — higher than 15% of readings in its estimated 7-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Beam Therapeutics Inc. (BEAM)?

The P/S ratio for BEAM stock is 16.08.

Is Beam Therapeutics Inc.'s P/S ratio high or low?

The P/S ratio of 16.08 is 42% below its estimated 5-year average of 27.93, near the low end of its estimated 5-year range (4.80–256772.76).

What is the estimated TTM average P/S ratio for Beam Therapeutics Inc. (BEAM)?

The estimated TTM average P/S ratio for BEAM stock is 30.85.

What is the estimated 3Y average P/S ratio for Beam Therapeutics Inc. (BEAM)?

The estimated 3Y average P/S ratio for BEAM stock is 21.15.

What is the estimated 5Y average P/S ratio for Beam Therapeutics Inc. (BEAM)?

The estimated 5Y average P/S ratio for BEAM stock is 27.93.

Showing the most recent 260 of 1,672 data points. The chart above shows the full history.

Related Metrics